Get the latest news, insights, and market updates on LQDA (Liquidia Corporation). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in June 2025Generated more than $30 million of positive cash flow during the fourth quarter 2025 MORRISVILLE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respi Jan 9, 2026 - $LQDA
Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference
MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Dr. Roger Jeffs, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 beginning at approximately 5:15 p.m. Pacific Time (8:15 p.m. Eastern Time) at the Westin St. Francis in San Francisco, California. Access to a live, audio-only webcast will be available on the “Investors” page of Liquidia’s website at https://liquidia Jan 7, 2026 - $LQDA
Is It Too Late to Consider Liquidia After Its 1,051% Five Year Surge?
If you are wondering whether Liquidia is still a smart bet after its huge run, you are not alone. This is exactly the kind of stock where valuation really matters. The share price has climbed 21.9% over the last month and is up 182.6% year to date, adding to an eye catching 202.3% gain over the past year and 1,051.2% over five years. Much of this momentum has been tied to growing optimism around its pulmonary hypertension franchise and regulatory progress on its lead therapy, which investors... Dec 16, 2025 - $LQDA
Arquitos Capital Management’s Updates on Liquidia Corporation (LQDA)
Arquitos Capital Management, an investment management firm, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. During the third quarter, the fund delivered a net return of 29.6% bringing year-to-date gains to an impressive 66.8%. Arquitos Capital Management is an unconventional hedge fund that focuses on a select group […] Dec 11, 2025 - $LQDA
Is It Too Late to Consider Liquidia After 140.6% Surge and Regulatory Milestone?
Wondering if Liquidia is truly a hidden gem or already priced for perfection? Let's take a closer look at what might make this stock a standout or a risk. Liquidia's shares have been on a tear, surging 140.6% year-to-date and up an incredible 173.3% over the past 12 months, signaling growing market conviction about the company's future. Fueling these eye-catching returns, the company recently reported progress in clinical trial developments and a new regulatory milestone for its lead... Nov 22, 2025 - $LQDA
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple